European equities traded in the US as American depositary receipts were tracking lower late Friday morning, declining 0.5% to 1,570.76 on the S&P Europe Select ADR Index, which is up 1% for the week.

From continental Europe, the gainers were led by consumer goods giant Unilever (UL) and internet advertising firm Criteo (CRTO), which rose 1.7% and 1.5% respectively. They were followed by oil and gas company TotalEnergies (TTE) and biopharmaceutical company DBV Technologies (DBVT), which were up 1.3% and 0.2% respectively.

The decliners from continental Europe were led by biotech firm Evaxion (EVAX) and biopharmaceutical company Cellectis (CLLS), which shed 27.4% and 10.8% respectively. They were followed by pharmaceutical company Novo Nordisk (NVO) and medical device manufacturer EDAP TMS (EDAP), which lost 4.1% and 2% respectively.

From the UK and Ireland, the gainers were led by educational publisher Pearson (PSO), which advanced 2.8%, followed by hospitality company InterContinental Hotels Group (IHG) and biopharmaceutical company Akari Therapeutics (AKTX), which rose 1.3% each.

The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Bicycle Therapeutics (BCYC), which dropped 7.5% and 5.3% respectively. They were followed by biotech firm Autolus Therapeutics and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which were down 5% and 3.8% respectively.